HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 437 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $86,958,141 | +26.2% | 751,453 | +12.2% | 0.09% | +28.6% |
Q2 2023 | $68,889,636 | +332.8% | 669,872 | +358.8% | 0.07% | +268.4% |
Q1 2023 | $15,917,621 | +7.8% | 145,993 | +12.2% | 0.02% | +11.8% |
Q4 2022 | $14,761,232 | +1973.2% | 130,103 | +1050.1% | 0.02% | +1600.0% |
Q3 2022 | $712,000 | -53.5% | 11,312 | -40.1% | 0.00% | -50.0% |
Q2 2022 | $1,530,000 | +139.4% | 18,883 | +213.4% | 0.00% | +100.0% |
Q1 2022 | $639,000 | -44.4% | 6,025 | -43.5% | 0.00% | 0.0% |
Q4 2021 | $1,150,000 | -2.8% | 10,657 | -1.1% | 0.00% | 0.0% |
Q3 2021 | $1,183,000 | -53.2% | 10,772 | -59.8% | 0.00% | -66.7% |
Q2 2021 | $2,526,000 | +6.5% | 26,776 | +3.8% | 0.00% | 0.0% |
Q1 2021 | $2,371,000 | +19.9% | 25,787 | -6.1% | 0.00% | 0.0% |
Q4 2020 | $1,977,000 | +430.0% | 27,453 | +474.8% | 0.00% | +200.0% |
Q3 2020 | $373,000 | -58.2% | 4,776 | -80.7% | 0.00% | -50.0% |
Q4 2019 | $892,000 | -25.5% | 24,716 | -43.8% | 0.00% | 0.0% |
Q3 2019 | $1,197,000 | – | 43,980 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 548,715 | $59,130,000 | 25.86% |
Paulson & Co. | 6,000,000 | $646,560,000 | 19.94% |
Avoro Capital Advisors LLC | 9,295,000 | $1,001,629,000 | 17.05% |
Asymmetry Capital Management, L.P. | 137,610 | $14,829,000 | 7.87% |
1492 Capital Management LLC | 119,995 | $12,931,000 | 6.37% |
Eversept Partners, LP | 833,750 | $89,844,900 | 5.74% |
HealthCor Management, L.P. | 832,270 | $89,685,000 | 4.88% |
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 1,063,236 | $114,574,000 | 4.38% |
PFM Health Sciences, LP | 1,091,840 | $117,657,000 | 4.01% |
Ikarian Capital, LLC | 246,900 | $26,607,000 | 3.96% |